ICAM-1, which controls the firm adhesion of neutrophils on the endothelium, has been extensively studied in relation to non-COVID-19 ICU outcome; ICAM-1 production has been shown to be associated with increased mortality [27,28]. This evidence concerns the gene ICAM1 and COVID-19.